This eases the burden on the country’s fragmented healthcare sector whilst preventing it from reaching overcapacity.
More recently, the government has moved ahead in increasing Polymerase Chain Reaction (PCR) testing capacity which aids in different aspects.
It also developed its own antigen and antibody rapid test helping to support surveillance and case mapping of the novel virus’ spread.
Read Also: Indonesia Seeks Partners for Coronavirus Vaccine Production
Drug trials of a possible vaccine developed by the Indonesian State Intelligence Agency (BIN), Airlangga University, and the Indonesian National Board for Disaster Management (BNPB) are being conducted.
The drug combination was founded by Airlangga University and will be distributed to hospitals if the drug trials prove successful. (Writer: Dandy Bayu Bramasta | Editor: Inggried Dwi Wedhaswary)
Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.